A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Rhoades Smith KE, Bilen MA. A review of papillary renal cell carcinoma and MET inhibitors. Kidney Cancer. 2019;3(3):151–161. doi:10.3233/KCA-190058
   PubMedGoogle Scholar
• Alomari AK, Nettey OS, Singh D, Kluger H, Adeniran AJ. Clinicopathological and immunohistochemical characteristics of papillary renal cell carcinoma with emphasis on subtyping. Hum Pathol. 2015;46(10):1418–1426. doi:10.1016/j.humpath.2015.06.006
   PubMed Web of Science ®Google Scholar
• Akhtar M, Al-Bozom IA, Al Hussain T. Papillary Renal Cell Carcinoma (PRCC): an update. Adv Anat Pathol. 2019;26(2):124–132. doi:10.1097/PAP.0000000000000220
   PubMed Web of Science ®Google Scholar
• Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34. doi:10.1186/s13045-019-0720-y
   PubMed Web of Science ®Google Scholar
• Latunde-Dada GO. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj. 2017;1861(8):1893–1900. doi:10.1016/j.bbagen.2017.05.019
   PubMed Web of Science ®Google Scholar
• Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130–143. doi:10.1016/j.freeradbiomed.2018.09.043
   PubMed Web of Science ®Google Scholar
• Chandra Gupta S, Nandan Tripathi Y. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140(9):1955–1967. doi:10.1002/ijc.30546
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang W, Zhu W, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019;20(22):22. doi:10.3390/ijms20225573
   Web of Science ®Google Scholar
• Wang C, Kawakami-Mori F, Kang L, et al. Low-dose L-NAME induces salt sensitivity associated with sustained increased blood volume and sodium-chloride cotransporter activity in rodents. Kidney Int. 2020;98(5):1242–1252. doi:10.1016/j.kint.2020.05.050
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang J, Wang J, Yu W, Yang J. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015. doi:10.3390/cells8091015
   PubMed Web of Science ®Google Scholar
• Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551. doi:10.1038/s41556-019-0311-8
   PubMed Web of Science ®Google Scholar
• Lu J, Xu F, Lu H. LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53. Life Sci. 2020;260:118305. doi:10.1016/j.lfs.2020.118305
   PubMed Web of Science ®Google Scholar
• Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329–2343. doi:10.1038/s41418-019-0304-y
   PubMed Web of Science ®Google Scholar
• Wang Z, Jensen MA, Zenklusen JC. A practical guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol. 2016;1418:111–141.
   PubMedGoogle Scholar
• Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford). 2020;2020. doi:10.1093/database/baaa021
   Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M. KEGG mapping tools for uncovering hidden features in biological data. Protein Sci. 2021. doi:10.1002/pro.4172
   PubMed Web of Science ®Google Scholar
• Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–632. doi:10.1021/acs.jproteome.8b00702
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–262. doi:10.1016/j.celrep.2016.12.019
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. doi:10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Shi J, Jiang D, Yang S, et al. LPAR1, correlated with immune infiltrates, is a potential prognostic biomarker in prostate cancer. Front Oncol. 2020;10:846. doi:10.3389/fonc.2020.00846
   PubMed Web of Science ®Google Scholar
• Yi M, Nissley DV, McCormick F, Stephens RM. ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications. Sci Rep. 2020;10(1):10258. doi:10.1038/s41598-020-66986-8
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Luo L, Zhou H, Su H. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis. BMC Cancer. 2021;21(1):553. doi:10.1186/s12885-021-08319-0
   PubMed Web of Science ®Google Scholar
• Liu Z, Wan Y, Yang M, et al. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas. Cancer Cell Int. 2020;20:235. doi:10.1186/s12935-020-01331-7
   PubMed Web of Science ®Google Scholar
• O’Brien SJ, Fiechter C, Burton J, et al. Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200/ZEB1/E-cadherin, vimentin signaling in colon adenocarcinoma. Cell Death Discov. 2021;7(1):61. doi:10.1038/s41420-021-00427-x
   PubMed Web of Science ®Google Scholar
• Chen SH, Lin F, Zhu JM, et al. An immune-related lncRNA prognostic model in papillary renal cell carcinoma: a lncRNA expression analysis. Genomics. 2021;113(1 Pt 2):531–540. doi:10.1016/j.ygeno.2020.09.046
   PubMed Web of Science ®Google Scholar
• Cheng G, Liu D, Liang H, Yang H, Chen K, Zhang X. A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. Aging (Albany NY). 2019;11(21):9597–9615. doi:10.18632/aging.102407
   PubMedGoogle Scholar
• Chen K, Gan JX, Huang ZP, Liu J, Liu HP. Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets. Bioengineered. 2021;12(1):875–885. doi:10.1080/21655979.2021.1888596
   PubMed Web of Science ®Google Scholar
• Zhao J, Song X, Xu T, et al. Identification of potential prognostic competing triplets in high-grade serous ovarian cancer. Front Genet. 2020;11:607722. doi:10.3389/fgene.2020.607722
   PubMed Web of Science ®Google Scholar
• Gong S, Xu M, Zhang Y, Shan Y, Zhang H. The prognostic signature and potential target genes of six long non-coding RNA in laryngeal squamous cell carcinoma. Front Genet. 2020;11:413. doi:10.3389/fgene.2020.00413
   PubMed Web of Science ®Google Scholar
• Zuo S, Wang L, Wen Y, Dai G. Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma. J Cell Biochem. 2018;120:7375.
   PubMed Web of Science ®Google Scholar
• Yang F, Song Y, Ge L, Zhao G, Liu C, Ma L. Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma. Oncol Lett. 2019;18(4):3691–3697. doi:10.3892/ol.2019.10684
   PubMed Web of Science ®Google Scholar
• Wen D, Huang Z, Li Z, et al. LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA. J Cell Physiol. 2020;235(10):7592–7603. doi:10.1002/jcp.29667
   PubMed Web of Science ®Google Scholar
• Li Y, Shen R, Wang A, et al. Construction of a prognostic immune-related LncRNA risk model for lung adenocarcinoma. Front Cell Dev Biol. 2021;9:648806. doi:10.3389/fcell.2021.648806
   PubMed Web of Science ®Google Scholar
• Fang S, Zhao Y, Hu X. LncRNA ADAMTS9-AS1 Restrains the aggressive traits of breast carcinoma cells via sponging miR-513a-5p. Cancer Manag Res. 2020;12:10693–10703. doi:10.2147/CMAR.S266575
   PubMed Web of Science ®Google Scholar
• Chen W, Tu Q, Yu L, et al. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer. Hum Cell. 2020;33(4):1133–1141. doi:10.1007/s13577-020-00388-w
   PubMed Web of Science ®Google Scholar
• Bai Y, Lin H, Chen J, Wu Y, Yu S. Identification of prognostic glycolysis-related lncRNA signature in tumor immune microenvironment of Hepatocellular carcinoma. Front Mol Biosci. 2021;8:645084. doi:10.3389/fmolb.2021.645084
   PubMed Web of Science ®Google Scholar
• Wang S, Chen X, Qiao T. Long noncoding RNA MIR44352HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR3835p/RBM3 axis. Oncol Rep. 2021;45(6). doi:10.3892/or.2021.8050
   Web of Science ®Google Scholar
• Xing P, Wang Y, Zhang L, Ma C, Lu J. Knockdown of lncRNA MIR44352HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/betacatenin signaling pathway. Int J Mol Med. 2021;47(6). doi:10.3892/ijmm.2021.4926
   Web of Science ®Google Scholar